Laboratory Corp. (NYSE: LH) reported Q2 EPS of $1.84, $0.07 better than the analyst estimate of $1.77. Revenue for the quarter came in at $1.52 billion versus the consensus estimate of $1.5 billion.

Laboratory Corp. sees FY2014 EPS of $6.50 - $6.75, versus prior guidance of $6.40 - $6.70 and the consensus of $6.68.

For earnings history and earnings-related data on Laboratory Corp. (LH) click here.